☆ 4.7 Editorial Material

Absolute Benefits From Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors

DIABETES CARE (2023)

Journal

DIABETES CARE

Volume 46, Issue 6, Pages 1143-1144

Publisher

AMER DIABETES ASSOC

DOI: 10.2337/dci23-0023

Keywords

-

Categories

Endocrinology & Metabolism

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.